Hemoglobin, platelets, bleeding, pericardial effusions, and intrapulmonary shunting top the monitoring list for patients with pulmonary arterial hypertension (PAH) starting with sotatercept, according to Vallerie McLaughlin, MD.
|Articles|November 8, 2021
Daily OTC Pearl: Swim-Ear (Isopropyl Alcohol Otic)
Author(s)Saro Arakelians, PharmD
Swim-Ear helps to soften, loosen, and remove earwax.
Advertisement
OTC/Lifestyle Pearl of the Day: Swim-Ear (Isopropyl Alcohol Otic)
Indication: This
Insight:
- Too much earwax can block the ear canal and reduce hearing.
- Mechanism of action: This medication releases oxygen and starts to foam when it comes in contact with the
skin . - The foaming helps break up and remove the earwax.
- Use under 12 years old should be recommended by a physician.
- Directions: Use the hands first. Apply this medication into the ear, usually twice daily or as directed by a physician. Do not use this medication for more than 4 days at a time.
- To make sure that the right amount of medication is given and to avoid touching the ear with the dropper, have another person administer the drops, if possible.
- To lower the risk of
dizziness , hold the container in your hand for a few minutes to warm it. - Avoid getting it in the eyes.
- Manufacturer: Sandoz
Sources:
Advertisement
Related to this article
Marie-Claire Seeley, RN, MNurs, PhD, discusses standing tests, medication review, and what inflammatory findings may mean for future POTS treatment.
AI-driven coding fuels specialty EHRs and telehealth tools, making ePrescribing faster, tailored, and affordable while shifting focus to workflow and compliance.
Approval spans early and levodopa-treated disease; a 6-week titration and CYP3A interactions put pharmacists at the center of starting therapy.
Novo Nordisk's top-line phase 3 data show 12.4% weight loss with CagriSema 1.0 mg/1.0 mg in type 2 diabetes and 21.0% in adults with overweight or obesity.
Researchers found substantial overlap in autonomic symptoms, orthostatic tachycardia, and functional impairment between long COVID and POTS.
A review of 69 studies finds influenza vaccines continue to reduce hospitalization and death, with no new safety concerns.
Isatuximab plus Iberdomide maintenance helps MRD-positive myeloma patients turn MRD-negative after transplant, with manageable safety.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Tavapadon, First D1/D5 Agonist for Parkinson Disease
2
Pharmacists Can Close CKD Medication Adherence Gaps, PHTI Says
3
FDA Approves Tiratricol, First Treatment for MCT8 Deficiency
4
CagriSema Tops Tirzepatide 5 mg for Weight Loss in REIMAGINE 5
5